| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 4e-12 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-12 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 5e-11 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |